The goal of this webinar is to discuss the evidence that supports proteinuria reduction as a surrogate marker in IgA Nephropathy clinical trials.

Proteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials

NephU is an engaged community of health care professionals and advocates collaborating to improve kidney health. Through increased awareness, collaboration, and information-sharing, our mission is to improve the future outcomes for individuals with kidney disease and other related conditions. Please visit https://nephu.org for more information

Share Proteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials

Sign up to save your podcasts

Proteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials

Proteinuria Reduction As A Surrogate Marker In IgAN Clinical Trials